- Home
- MLYS vs VLGEA Comparison
MLYS vs VLGEA Comparison
Compare MLYS & VLGEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLYS | VLGEA |
|---|---|---|
| Founded | 2019 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 592.3M |
| IPO Year | 2023 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MLYS | VLGEA |
|---|---|---|
| Price | $26.23 | $42.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $47.33 | N/A |
| AVG Volume (30 Days) | ★ 988.0K | 34.1K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ 37.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,612,015,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.31 |
| Revenue Growth | N/A | ★ 0.46 |
| 52 Week Low | $10.44 | $30.08 |
| 52 Week High | $47.65 | $41.58 |
Technical Indicators
Market Signals| Indicator | MLYS | VLGEA |
|---|---|---|
| Relative Strength Index (RSI) | 37.90 | 67.41 |
| Support Level | $13.42 | $36.20 |
| Resistance Level | $30.05 | N/A |
| Average True Range (ATR) | 1.86 | 1.31 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 16.90 | 89.96 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.